Citation data

CrossRef

Works that cite this article, indexed by Crossref.

59 resultsUpdated October 25, 2026

← Back to article

In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases

Infectious Disorders - Drug Targets 21(4) (2021)

Trinath Chowdhury; Gourisankar Roymahapatra; Santi M. Mandal

Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study

Informatics in Medicine Unlocked 19 (2020)

K. Abraham Peele; Chandrasai Potla Durthi; T. Srihansa; S. Krupanidhi; Vijaya Sai Ayyagari; D. John Babu; M. Indira; A. Ranganadha Reddy; T.C. Venkateswarulu

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development

Journal of Gynecology Obstetrics and Human Reproduction 49(10) (2020)

Guilherme Antonio de Souza Silva; Suéllen Pedrosa da Silva; Marcos Aurélio Santos da Costa; Abdênego Rodrigues da Silva; Robson Raion de Vasconcelos Alves; Fernanda das Chagas Ângelo Mendes Tenório; Alanne Rayssa da Silva Melo; Antonio Carlos de Freitas; Cristiane Moutinho Lagos de Melo

Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report

American Journal of Transplantation 20(7) (2020)

Ling Ning; Lei Liu; Wenyuan Li; Hongtao Liu; Jizhou Wang; Ziqin Yao; Shengyu Zhang; Desheng Zhao; Björn Nashan; Aizong Shen; Lianxin Liu; Lei Li

Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus

International Journal of Biological Macromolecules 183 (2021)

Yuxi Guo; Xuefeng Chen; Pin Gong

Integrating LC–MS/MS and In Silico Methods to Uncover Bioactive Compounds with Lipase Inhibitory Potential in the Antarctic Moss Warnstorfia fontinaliopsis

Applied Biochemistry and Biotechnology 197(4) (2025)

Hirotake Yamaguchi; Ryoichi Yamada; Kristina Lama; Ui Joung Youn; Jun Hyuck Lee; Tae-Jin Oh

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach

Indian Journal of Pharmacology 52(1) (2020)

Phulen Sarma; Manisha Prajapat; Pramod Avti; Hardeep Kaur; Subodh Kumar; Bikash Medhi

Untitled

Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19

European Journal of Clinical Pharmacology 77(9) (2021)

Nils von Hentig

Available Antiretrovirals in the Treatment and Pre-Exposure Prophylaxis of SARS-CoV-2: Quo Vadis?

Intervirology 64(1) (2021)

Miguel Alpalhão; Paulo Filipe

Natural Products as Anti-COVID-19 Agents: An In Silico Study

Coronaviruses 2(5) (2021)

Chandan Sarkar; Sarmin Jamaddar; Milon Mondal; Abul Bashar Ripon Khalipha; Muhammad Torequl Islam; Mohammad S. Mubarak

Targeting COVID-19 pandemic: in silico evaluation of 2-hydroxy-1, 2-diphenylethanone N(4)-methyl-N(4)-phenylthiosemicarbazone as a potential inhibitor of SARS-CoV-2

Structural Chemistry 34(5) (2023)

Rajan Jeevana; Abu Pilakkaveettil Kavitha; Thoppilan G. Abi; Pookkottu K. Sajith; Jibin K. Varughese; Kuttamath Kunniyur Aravindakshan

Computational Approaches for Lead Discovery against SARS-CoV-2 3C-Like Protease: Virtual Screening and Molecular Dynamics Studies

Journal of Medicine and Health Studies (2023)

Mohammad Kalim Ahmad Khan; Feras Almarshad

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates

F1000Research 9 (2020)

Yu Wai Chen; Chin-Pang Bennu Yiu; Kwok-Yin Wong

Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study

Journal of Biomolecular Structure and Dynamics 40(23) (2022)

Karim Mahnam; Zahra Ghobadi

Drug Safety Issues in Therapy COVID-19

The Russian Archives of Internal Medicine 10(3) (2020)

D. G. Levitova; S. A. Gracheva; A. S. Samoylov; U. D. Udalov; E. A. Praskurnichiy; O. V. Parinov

Safety perspectives on presently considered drugs for the treatment of COVID‐19

British Journal of Pharmacology 177(19) (2020)

Sophie L. Penman; Robyn T. Kiy; Rebecca L. Jensen; Christopher Beoku‐Betts; Ana Alfirevic; David Back; Saye H. Khoo; Andrew Owen; Munir Pirmohamed; B. Kevin Park; Xiaoli Meng; Christopher E. Goldring; Amy E. Chadwick

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus

Current Medicinal Chemistry 27(27) (2020)

Michele Costanzo; Maria Anna Rachele De Giglio; Giovanni Nicola Roviello

Investigating the mechanisms of ethanol-induced disruption of COVID-19 lipid bilayers through molecular dynamics simulations

Journal of Molecular Modeling 31(4) (2025)

Azadeh Kordzadeh; Ahmad Ramazani SA

Untitled

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment

Journal of the International AIDS Society 23(4) (2020)

Nathan Ford; Marco Vitoria; Ajay Rangaraj; Susan L Norris; Alexandra Calmy; Meg Doherty

RETRACTED ARTICLE: A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort

European Journal of Clinical Microbiology & Infectious Diseases 40(2) (2021)

Yasemin Cag; Sacit Icten; Burcu Isik-Goren; Naciye Betul Baysal; Begum Bektas; Ece Selvi; Pinar Ergen; Ozlem Aydin; Ayse Canan Ucisik; Fatma Yilmaz-Karadag; Hulya Caskurlu; Tulin Akarsu-Ayazoglu; Hasan Kocoglu; Sinan Uzman; Muge Nural-Pamukcu; Ferhat Arslan; Gurhan Bas; Mahmut Tayyar Kalcioglu; Haluk Vahaboglu

Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2

Molecular Biology and Evolution 38(2) (2021)

Erica T Prates; Michael R Garvin; Mirko Pavicic; Piet Jones; Manesh Shah; Omar Demerdash; B Kirtley Amos; Armin Geiger; Daniel Jacobson; Malik Harmit

Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery

Current Drug Research Reviews 13(2) (2021)

Supriya Roy; Suneela Dhaneshwar; Bhavya Bhasin

An Overview of COVID-19: Focus on Pharmacological Aspect

SBV Journal of Basic, Clinical and Applied Health Science 3(2) (2020)

Nandhini Saravanabavan; Padmavathi Shanmuganathan; Manimekalai Kumarappan; Kartik J Salwe; Barathane Datchanamurthy; Johan Pandian; R Sudar Codi; Vimala Ananthy; Kamalasundar Thanuskodi; Uma Narayanamurthy

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective

Journal of Pharmaceutical Sciences 110(3) (2021)

Simone Perazzolo; Linxi Zhu; Weixian Lin; Alexander Nguyen; Rodney J.Y. Ho

Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction

Virology 604 (2025)

Ankita Saha; Shweta Choudhary; Priyanshu Walia; Pravindra Kumar; Shailly Tomar

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

RSC Advances 10(45) (2020)

Gamal El-Din A. Abuo-Rahma; Mamdouh F. A. Mohamed; Tarek S. Ibrahim; Mai E. Shoman; Ebtihal Samir; Rehab M. Abd El-Baky

Lipophilic Efficiency as an Important Metric in the Design of SARS coronavirus 3C-like proteinase (3CL-pro) Inhibitors: Guidepost towards Lead Selection and Optimization in the Treatment of COVID-19

ASRIC Journal on Health Sciences 1(1) (2021)

George Oche Ambrose; Joseph Enya; Tamonokorite AbelJack-Soala; Bukola Temitope Fabunmi; Ajayi Kolawole Temidayo; Bankole Olukayode Olusola

A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach

Informatics in Medicine Unlocked 21 (2020)

Sahar Obi Abd Albagi; Mosab Yahya Al-Nour; Mustafa Elhag; Asaad Tageldein Idris Abdelihalim; Esraa Musa Haroun; Mohammed Elmujtba Adam Essa; Mustafa Abubaker; Hemchandra Deka; Arabinda Ghosh; Mohammed A. Hassan

Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study

Structural Chemistry 31(5) (2020)

Nouman Rasool; Ammara Akhtar; Waqar Hussain

FDA recommended potent drugs against COVID-19: Insight through molecular docking

Materials Today: Proceedings 45 (2021)

Khushbu Gumber; Pomila

Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses

Molecules 25(8) (2020)

Nakarin Suwannarach; Jaturong Kumla; Kanaporn Sujarit; Thanawat Pattananandecha; Chalermpong Saenjum; Saisamorn Lumyong

The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course

Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 15(1) (2021)

N. V. Bobkova

COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling

AIDS Care 34(7) (2022)

S. Q. Rocha; V. I. Avelino-Silva; M. V. Tancredi; L. F. Jamal; P. R. A. Ferreira; A. Tayra; P. M. Ferreira; T. Carvalhanas; C. S. B. Domingues; R. A. Souza; M. C. Gianna; A. O. Kalichman; O. H. M. Leite; T. N. L. Souza; D. A. Gomes e Costa; J. J. D. Furtado; A. F. Costa

An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia

PLOS ONE 16(6) (2021)

Purwati; Andang Miatmoko; Nasronudin; Eryk Hendrianto; Deya Karsari; Aristika Dinaryanti; Nora Ertanti; Igo Syaiful Ihsan; Disca Sandyakala Purnama; Tri Pudy Asmarawati; Erika Marfiani; Yulistiani; Alfian Nur Rosyid; Prastuti Asta Wulaningrum; Herley Windo Setiawan; Imam Siswanto; Ni Nyoman Tri Puspaningsih; Mrinmoy Sanyal

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India

Indian Journal of Medical Research 151(2-3) (2020)

Tarun Bhatnagar; Manoj V. Murhekar; Manish Soneja; Nivedita Gupta; Sidhartha Giri; Naveet Wig; Raman Gangakhedkar

Therapeutic opportunities of edible antiviral plants for COVID-19

Molecular and Cellular Biochemistry 476(6) (2021)

Bhoomika Patel; Supriya Sharma; Nisha Nair; Jaseela Majeed; Ramesh K. Goyal; Mahaveer Dhobi

Current pharmacological treatments for COVID‐19: What's next?

British Journal of Pharmacology 177(21) (2020)

Cristina Scavone; Simona Brusco; Michele Bertini; Liberata Sportiello; Concetta Rafaniello; Alice Zoccoli; Liberato Berrino; Giorgio Racagni; Francesco Rossi; Annalisa Capuano

Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock

VirusDisease 31(2) (2020)

Dipti Mothay; K. V. Ramesh

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

International Journal of Molecular Sciences 21(9) (2020)

Maria Bzówka; Karolina Mitusińska; Agata Raczyńska; Aleksandra Samol; Jack A. Tuszyński; Artur Góra

COVID-19: a wreak havoc across the globe

Archives of Physiology and Biochemistry 129(1) (2023)

Heena Rehman; Md Iftekhar Ahmad

Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (Mpro) of SARS-CoV-2

Journal of Molecular Modeling 27(3) (2021)

Arabinda Ghosh; Monoswi Chakraborty; Anshuman Chandra; Mohamad Parvez Alam

COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach

Drug Design, Development and Therapy Volume 15 (2021)

Soha R Abd El Hadi; Esmat E Zien El-Deen; Mostafa M Bahaa; Abdelfattah A Sadakah; Heba A Yassin

In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach

Journal of Biomolecular Structure and Dynamics 39(17) (2021)

Papia Chowdhury

Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study

Journal of Physics: Conference Series 1797(1) (2021)

Tanmoy Dutta; Sajal Ghorai; Abdul Ashik Khan; Nabajyoti Baildya; Narendra Nath Ghosh

Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study

Journal of Biomolecular Structure and Dynamics 40(12) (2022)

Vanderlan Nogueira Holanda; Elton Marlon de Araújo Lima; Welson Vicente da Silva; Rafael Trindade Maia; Rafael de Lima Medeiros; Arabinda Ghosh; Vera Lúcia de Menezes Lima; Regina Celia Bressan Queiroz de Figueiredo

Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19

Mini-Reviews in Medicinal Chemistry 21(8) (2021)

Ekta Shirbhate; Preeti Patel; Vijay K Patel; Ravichandran Veerasamy; Prabodh C Sharma; Barij N Sinha; Harish Rajak

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates

F1000Research 9 (2020)

Yu Wai Chen; Chin-Pang Bennu Yiu; Kwok-Yin Wong

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening

Journal of Clinical Medicine 9(7) (2020)

Cristina Adriana Dehelean; Voichita Lazureanu; Dorina Coricovac; Marius Mioc; Roxana Oancea; Iasmina Marcovici; Iulia Pinzaru; Codruta Soica; Aristidis M. Tsatsakis; Octavian Cretu

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

Computational and Structural Biotechnology Journal 18 (2020)

Bo Ram Beck; Bonggun Shin; Yoonjung Choi; Sungsoo Park; Keunsoo Kang

Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights

Biophysical Reviews 17(2) (2025)

Fernando Luís Barroso da Silva; Karen Paco; Aatto Laaksonen; Animesh Ray

Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis

Pharmaceuticals 14(4) (2021)

Magdi E. A. Zaki; Sami A. Al-Hussain; Vijay H. Masand; Siddhartha Akasapu; Sumit O. Bajaj; Nahed N. E. El-Sayed; Arabinda Ghosh; Israa Lewaa